English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/124286
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorMartorell, Òscar-
dc.contributor.authorBarriga, Francisco M.-
dc.contributor.authorMerlos-Suárez, Anna-
dc.contributor.authorAttolini, Camille Stephan Otto-
dc.contributor.authorCasanova, Jordi-
dc.contributor.authorBatlle, Eduard-
dc.contributor.authorSancho, Elena-
dc.contributor.authorCasali, Andreu-
dc.identifierdoi: 10.15252/embr.201438622-
dc.identifierissn: 1469-3178-
dc.identifier.citationEMBO Reports 15(11): 1210-1218 (2014)-
dc.description.abstract© 2014 The Authors. Activating mutations in Wnt and EGFR/Ras signaling pathways are common in colorectal cancer (CRC). Remarkably, clonal coactivation of these pathways in the adult Drosophila midgut induces >tumor-like> overgrowths. Here, we show that, in these clones and in CRC cell lines, Dpp/TGF-β acts as a tumor suppressor. Moreover, we discover that the Iroquois/IRX-family-protein Mirror downregulates the transcription of core components of the Dpp pathway, reducing its tumor suppressor activity. We also show that this genetic interaction is conserved in human CRC cells, where the Iro/IRX proteins IRX3 and IRX5 diminish the response to TGF-β. IRX3 and IRX5 are upregulated in human adenomas, and their levels correlate inversely with the gene expression signature of response to TGF-β. In addition, Irx5 expression confers a growth advantage in the presence of TGF-β, but is selected against in its absence. Together, our results identify a set of Iro/IRX proteins as conserved negative regulators of Dpp/TGF-β activity. We propose that during the characteristic adenoma-to-carcinoma transition of human CRC, the activity of IRX proteins could reduce the sensitivity to the cytostatic effect of TGF-β, conferring a growth advantage to tumor cells prior to the acquisition of mutations in TGF-β pathway components.-
dc.description.sponsorshipO.M. is a recipient of a FPU fellowship from the MEC, and F.M.B holds an IRB/PhD La Caixa fellowship. This work was supported by the MICINN (BFU2010-16016 and BFU2011-23479) to A.C.-
dc.publisherNature Publishing Group-
dc.publisherEuropean Molecular Biology Organization-
dc.titleIro/IRX transcription factors negatively regulate Dpp/TGF-β pathway activity during intestinal tumorigenesis-
dc.description.versionPeer Reviewed-
dc.contributor.funderMinisterio de Ciencia e Innovación (España)-
dc.contributor.funderMinisterio de Educación y Ciencia (España)-
dc.contributor.funderLa Caixa-
Appears in Collections:(IBMB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show simple item record

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.